Key result
Maternal Coxsackievirus B3 infection during early gestation (E7-E9) induced congenital heart defects in 37.3% of viable mouse fetuses, primarily ventricular septal defects, by suppressing cardiomyocyte proliferation.
Why the study?
It was hypothesized that CVB3, which targets cardiomyocytes via Coxsackie and Adenovirus Receptor expressed in fetal hearts, can precipitate congenital heart defects when infection occurs during a critical gestational window.
Does prenatal Coxsackievirus B3 infection induce congenital heart defects in a fetal mouse model?
Does prenatal Coxsackievirus B3 infection induce congenital heart defects in a fetal mouse model?
Maternal Coxsackievirus B3 infection during a critical early gestation window induces congenital heart defects in mice by suppressing fetal cardiomyocyte proliferation.
Answers are grounded in this paper and cite their sources.
Fetal CVB3 exposure may precipitate CHD in mice; hypothesis-generating and leaves open human relevance.
Aims Coxsackievirus B (CVB), the most common cause of viral myocarditis, targets cardiomyocytes through Coxsackie and Adenovirus Receptor, which is highly expressed in the fetal heart. We hypothesized CVB3, a well-recognized culprit for viral myocarditis, can precipitate congenital heart defects (CHD), when fetal infection occurs during critical window of gestation. Methods & Results We infected C57Bl/6 pregnant mice with CVB3 during serial time points in early gestation (E5, E7, E9 and E11). We used different viral titers to examine possible dose- response relationship and assessed viral loads in various fetal organs as well as kinetics of virus passage into the fetus during gestation. Provided viral exposure occurred between E7-E9, we observed characteristic features of ventricular septal defect (33.6%), abnormal myocardial architecture resembling non-compaction (23.5%), and double outlet right ventricle (4.4%) among 209 viable fetuses examined. We observed a direct relationship between viral titers, severity and incidence of CHD, with apparent predominance among female fetuses. Infected dams remained healthy; we did not observe any maternal heart or placental injury suggestive of direct viral effects on developing heart as likely cause of CHD. We examined signaling pathways in CVB3-exposed hearts using RNAseq, KEGG enrichment analysis and immunohistochemistry. Signaling proteins of the Hippo, tight junction, transforming growth factor β1 and extracellular matrix proteins were the most highly enriched in CVB3-infected fetuses with VSD (log fold change >1.9, P<0.02). Moreover, cardiomyocyte proliferation was 50% lower in fetuses with VSD compared with uninfected controls. Conclusion Prenatal CVB3 infection can induce CHD, provided the infection occurs during a critical window. Alterations in myocardial proliferate capacity and consequent changes in cardiac architecture and trabeculation appear to account for the majority of observed phenotypes.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2020) studied Congenital Heart Defects (n=49). Coxsackievirus B3 (CVB3) infection vs. Uninfected control was evaluated on Incidence of congenital heart defects (CHD) in viable fetuses (p=0.00002). Maternal Coxsackievirus B3 infection during early gestation (E7-E9) induced congenital heart defects in 37.3% of viable mouse fetuses, primarily ventricular septal defects, by suppressing cardiomyocyte proliferation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: